• 咨询热线
    客服服务热线 13671568941/15317326293
  • 在线咨询
  • 微信客服
    微信客服
  • 公众号
    扫码关注公众号

Chenodeoxycholic Acid sodium salt

CAS No. 2646-38-0

Chenodeoxycholic Acid sodium salt ( —— )

产品货号. M35851 CAS No. 2646-38-0

Chenodeoxycholic acid sodium 是一种疏水初级胆汁酸,能够活化核受体 FXR,该受体与胆固醇代谢有关。

纯度: >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
规格 价格/人民币 库存 数量
100MG ¥237 有现货
500MG ¥390 有现货
1G 获取报价 有现货

生物学信息

  • 产品名称
    Chenodeoxycholic Acid sodium salt
  • 注意事项
    本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
  • 产品简述
    Chenodeoxycholic acid sodium 是一种疏水初级胆汁酸,能够活化核受体 FXR,该受体与胆固醇代谢有关。
  • 产品描述
    Chenodeoxycholic acid sodium is a hydrophobic primary bile acid that activates nuclear receptors (FXR) involved in cholesterol metabolism.
  • 体外实验
    Chenodeoxycholic acid sodium (CDCA) and Deoxycholic acid (DCA) both inhibit 11 beta HSD2 with IC50 values of 22 mM and 38 mM, respectively and causes cortisol-dependent nuclear translocation and increases transcriptionalactivity of mineralocorticoid receptor (MR). Chenodeoxycholic acid sodium is able to stimulate Ishikawa cell growth by inducing a significant increase in Cyclin D1 protein and mRNA expression through the activation of the membrane G protein-coupled receptor (TGR5)-dependent pathway. Chenodeoxycholic acid sodium (CDCA) induces LDL receptor mRNA levels approximately 4 fold and mRNA levels for HMG-CoA reductase and HMG-CoA synthase two fold in a cultured human hepatoblastoma cell line, Hep G2. Chenodeoxycholic acid sodium-induced Isc is inhibited (≥67%) by Bumetanide, BaCl2, and the cystic fibrosis transmembrane conductance regulator (CFTR) inhibitor CFTRinh-172. Chenodeoxycholic acid sodium-stimulated Isc is decreased 43% by the adenylate cyclase inhibitor MDL12330A and Chenodeoxycholic acid sodium increases intracellular cAMP concentration. Chenodeoxycholic acid sodium treatment activates C/EBPβ, as shown by increases in its phosphorylation, nuclear accumulation, and expression in HepG2 cells. Chenodeoxycholic acid sodium enhances luciferase gene transcription from the construct containing -1.65-kb GSTA2 promoter, which contains C/EBP response element (pGL-1651). Chenodeoxycholic acid sodium treatment activates AMP-activated protein kinase (AMPK), which leads to extracellular signal-regulated kinase 1/2 (ERK1/2) activation, as evidenced by the results of experiments using a dominant-negative mutant of AMPKα and chemical inhibitor.
  • 体内实验
    ——
  • 同义词
    ——
  • 通路
    Metabolic Enzyme/Protease
  • 靶点
    FXR
  • 受体
    FXR
  • 研究领域
    ——
  • 适应症
    ——

化学信息

  • CAS Number
    2646-38-0
  • 分子量
    414.55
  • 分子式
    C24H39NaO4
  • 纯度
    >98% (HPLC)
  • 溶解度
    ——
  • SMILES
    [Na+].C[C@H](CCC([O-])=O)[C@H]1CC[C@H]2[C@@H]3[C@H](O)C[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@]12C
  • 化学全称
    ——

运输与储存

  • 储存条件
    (-20℃)
  • 运输条件
    With Ice Pack
  • 稳定性
    ≥ 2 years

参考文献

1. Stauffer AT, et al. Chenodeoxycholic acid and deoxycholic acid inhibit 11 beta-hydroxysteroid dehydrogenase type 2 and cause cortisol-induced transcriptional activation of the mineralocorticoid receptor. J Biol Chem. 2002 Jul 19;277(29):26286-92?
产品手册
关联产品
  • Vonafexor

    Vonafexor (EYP001) 是一种选择性FXR具有抗 HBV 作用的激动剂。

  • Tropifexor

    Tropifexor (LJN-452, LJN452) 是一种新型高效、选择性、口服活性 FXR 完全激动剂,EC50 为 0.26 nM。

  • GSK-2324

    GSK-2324 (GSK2324) 是一种有效的、选择性的、完全 FXR 激动剂,在 FRET 测定中 EC50 为 120 nM。